A trial looking at a drug called MK-5684 for prostate cancer that has spread
This trial is looking at a drug called MK-5684 for people with prostate cancer that has spread to another part of the body and has started to grow again.
This trial is looking at a drug called MK-5684 for people with prostate cancer that has spread to another part of the body and has started to grow again.
This trial is comparing whole body MRI scans to bone and CT scans to find out which is better at showing how well treatment is working.
This study is looking at using a new scan called a LI-MRI to test for prostate cancer before men have symptoms.
This trial is comparing stereotactic body radiotherapy to the prostate with stereotactic body radiotherapy to the prostate and lymph nodes in the pelvis.
This trial is looking at PSA blood tests and regular MRI scans for men having monitoring for prostate cancer.
This study is looking at 2 new ways of using an MRI scan to see changes in prostate cancer.
This study is looking at a way to assess the clear margins of tissue samples taken during prostate surgery.
This trial is comparing partial ablation treatment with radical treatment for prostate cancer.
This trial is looking at having saruparib or darolutamide before surgery to remove prostate cancer.
This study compares the standard of care MRI (SOC MRI) scan with the luminal index MRI scan to diagnose prostate cancer.